Founders Capital Management Ocular Therapeutix, Inc Transaction History
Founders Capital Management
- $148 Million
- Q1 2024
A detailed history of Founders Capital Management transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Founders Capital Management holds 2,000 shares of OCUL stock, worth $13,680. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,000
Previous 2,000
-0.0%
Holding current value
$13,680
Previous $8,000
125.0%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding OCUL
# of Institutions
148Shares Held
123MCall Options Held
185KPut Options Held
507K-
Summer Road LLC West Palm Beach, FL14.4MShares$98.2 Million100.0% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$87.3 Million9.97% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.7MShares$87 Million3.82% of portfolio
-
Black Rock Inc. New York, NY8.06MShares$55.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.24MShares$49.5 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $526M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...